Lawrence Cher

Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

Michael Weller, Nicholas Butowski, David Tran et al. · The Lancet Oncology · 2017 · 1.1K citations

Medicine, Oncology, Pharmacology +13

Phase III Randomized Trial Comparing the Efficacy of Cediranib As Monotherapy, and in Combination With Lomustine, Versus Lomustine Alone in Patients With Recurrent Glioblastoma

Tracy T. Batchelor, Paul Mulholland, Bart Neyns et al. · Journal of Clinical Oncology · 2013 · 598 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase III Study of Enzastaurin Compared With Lomustine in the Treatment of Recurrent Intracranial Glioblastoma

Wolfgang Wick, Vinay K. Puduvalli, Marc C. Chamberlain et al. · Journal of Clinical Oncology · 2010 · 514 citations

Medicine, Oncology, Pharmacotherapy +16

Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: long-term outcome

Jon Glass, Michael L. Gruber, Lawrence Cher et al. · Journal of neurosurgery · 1994 · 341 citations

Medicine, Oncology, Radiation Oncology +10

A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma

Alba A. Brandes, Santosh Kesari, Juan Manuel Sepúlveda-Sánchez et al. · Neuro-Oncology · 2016 · 271 citations · Full text

Medicine, Oncology, Pharmacology +17